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Genetic Analysis and Prevalence Studies of the brp
Exopolysaccharide Locus of Vibrio vulnificus
Katherine L. Garrison-Schilling, Zelam M. Kaluskar, Bliss Lambert, Gregg S. Pettis*
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, United States of America
Abstract
Phase variation in the Gram-negative human pathogen Vibrio vulnificus involves three colonial morphotypes- smooth
opaque colonies due to production of capsular polysaccharide (CPS), smooth translucent colonies as the result of little or no
CPS expression, and rugose colonies due to production of a separate extracellular polysaccharide (EPS), which greatly
enhances biofilm formation. Previously, it was shown that the brp locus, which consists of nine genes arranged as an
operon, is up-regulated in rugose strains in a c-di-GMP-dependent manner, and that plasmid insertions into the locus
resulted in loss of rugosity and efficient biofilm production. Here, we have used non-polar mutagenesis to assess the
involvement of individual brp genes in production of EPS and related phenotypes. Inactivation of genes predicted to be
involved in various stages of EPS biosynthesis eliminated both the rugose colonial appearance and production of EPS, while
knockout of a predicted flippase function involved in EPS transport resulted in a dry, lightly striated phenotype, which was
associated with a reduction of brp-encoded EPS on the cell surface. All brp mutants retained the reduced motility
characteristic of rugose strains. Lastly, we provide evidence that the brp locus is highly prevalent among strains of V.
vulnificus.
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Introduction
Vibrio vulnificus is a Gram-negative bacterium found in estuarine
and marine waters, and is commonly associated with human
disease caused by ingestion of raw oysters or contact of the
organism with an open wound. The mortality rate of V. vulnificus is
the highest among food-borne pathogens, ranging from 50–75%
[1], and pathogenesis is directly related to the presence of capsular
polysaccharide (CPS), which protects the bacteria from the host
immune system [2–5]. Encapsulated strains exhibit a smooth
opaque colony phenotype on agar plates and kill an iron-
overloaded mouse at lower doses than attenuated unencapsulated
strains, which exhibit a smooth translucent phenotype [3]. A third
colony type called rugose has been isolated from both opaque and
translucent parental strains, and it is characterized by dry,
wrinkled colonies, decreased motility, and robust biofilm forma-
tion caused by production of extracellular polysaccharide (EPS)
[6,7].
V. vulnificus can spontaneously switch among opaque, translu-
cent and rugose phases in response to certain environmental
conditions [8,9]. Genetic loci relevant to these switching events
include the group I CPS operon, involved in CPS biosynthesis and
transport [10,11], and the brp locus, which was shown to be
involved in EPS production [7,12]. The brp cluster (renamed from
wcr) was originally identified by RT-PCR analysis as being more
highly expressed in rugose variants when compared to opaque or
translucent ones [7]. The translucent phenotype of a transposon
mutant (TDB3[T]), which contains an insertion in the brp gene
cluster, raised the possibility that one or more brp genes may also
be required for CPS production [7,13].
The brp locus is regulated by bacterial second messenger c-di-
GMP, though the mechanism remains undetermined [12]. The
importance of c-di-GMP as a regulator of EPS production, and
biofilm formation has been established previously in several
bacterial species [14,15]. Recently, an additional exopolysacchar-
ide locus, rbd, was characterized in V. vulnificus, and it was found to
enhance biofilm and cell aggregation phenotypes, though its
polysaccharide did not appear to be required for either
development or maintenance of the rugose phenotype [16].
In this study, we used a non-polar mutagenesis approach to
assess the involvement of individual brp genes in exopolysaccharide
production and related phenotypes. Four brp genes were disrupted,
and two phenotypes with respect to colony morphology and EPS
production were observed. All non-polar brp mutants showed
greatly reduced biofilm capability and also remained less motile
than opaque or translucent variants. Through a combined PCR
and Southern blotting approach, we also found the brp locus to be
widespread within this species.
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Materials and Methods
Bacterial strains & growth conditions
All V. vulnificus strains were grown in heart infusion broth (Difco)
supplemented to 2% NaCl (HI) and on HI agar plates containing
18 g/l of agar (Difco). Broth cultures were incubated at 30uC and
200 rpm; plates were incubated overnight (ON) for 16–24 h at
30uC. Phase switching assays in HI and growth curves were all
performed as previously described [8]. Escherichia coli strains were
grown in LB broth (Difco), broth cultures were incubated at 37uC
and 250 rpm, and plates were incubated ON for 16–24 h at 37uC.
Antibiotics (Sigma) were used at the following concentrations:
150 mg/ml kanamycin, 50 mg/ml ampicillin, and 2 mg/ml chlor-
amphenicol for V. vulnificus and 50 mg/ml kanamycin, 50 mg/ml
ampicillin, and 10 mg/ml chloramphenicol for E. coli. Arabinose
(Sigma) was typically added to a final concentration of 0.2% when
needed. E. coli and V. vulnificus strains used or created in this study
are listed in Table 1.
Molecular genetic and recombinant DNA techniques
DNA manipulations were carried out using standard molecular
techniques [17]. Restriction enzymes, calf intestinal alkaline
phosphatase (CIP), T4 polynucleotide kinase, and Klenow
polymerase were obtained from New England Biolabs, Pfu
polymerase from Stratagene, AmpliTaq polymerase from Applied
Biosystems, and primers from Sigma Genosys. Plasmids used or
created in this study are listed in Table 2, while primers are listed
in Tables 3 and 4. Genomic DNA was isolated and PCRs for brp
gene linkage analysis were completed as described [7,8]. For
Southern blotting, fragments specific for the brpC or brpI genes
were generated via PCR with primer pairs RUG17/RUG18, and
CAP27/CAP28, respectively. Production of radiolabeled probes
and hybridizations were performed as described [7] using ca.
108 cpm/ml of probe per hybridization.
Generation of in-frame brpD and brpI insertion mutants
Mutants of brpD and brpI were generated from the rugose
parental strain KG3(R) as follows. Using PCR, ,1-kb fragments
of brpD and brpI were amplified using primer pairs Npm1/Npm2
and Npm3/Npm4, respectively. Each 50-ml PCR reaction mixture
contained 5 ml of 106 buffer, 4 ml of a 10 mM dNTP mixture
(each dNTP at 2.5 mM), 1 ml of each primer (20 mM), 1 ml of Pfu
polymerase (2.5 U/ml), 100 ng of YJ016 genomic DNA, and
nuclease-free H2O. The PCRs were performed using an initial
temperature of 95uC for 2 min, followed by 30 cycles of 95uC for
45 sec, 55uC for 45 sec, and 72uC for 1.5 min; these cycles were
then followed by a final extension at 72uC for 10 min and holding
at 4uC. PCR mixtures were examined by gel electrophoresis, and,
upon relevant restriction enzyme digestion, the 1-kb products were
cloned into the EcoRI and EcoRV sites and the EcoRI and XhoI
sites of vector pSP72 (Promega) to create pVV1 (brpD) and pVV4
(brpI), respectively. An 840-bp nonpolar kanamycin-resistance
cassette [18], which was generated by digestion of plasmid pKan2
with SmaI, was cloned in the correct orientation into the ClaI site
(which had been blunt ended using Klenow) of pVV1 or the MscI
site of pVV4 to create pVV2 and pVV8, respectively. To confirm
the cassette was inserted in frame with the downstream portion of
brpD and brpI, sequencing reactions were performed using BigDye
v3.1 (Applied Biosystems) [8]. The 1.88-kb HpaI-SmaI fragment of
pVV2 and the 1.75-kb EcoRI-XhoI fragment (whose ends were
filled in using Klenow) of pVV8 were then cloned into the blunt-
ended XbaI site of suicide vector pGP704sacB28 [19] to create
pVV21 (brpD) and pVV18 (brpI). Matings between V. vulnificus
KG3(R) and S17.1lpir harboring the respective insertion plasmids
were carried out on filter membranes; kanamycin-resistant,
ampicillin-sensitive transconjugants that had undergone double
homologous recombination were selected, and PCRs using
AmpliTaq polymerase and primer pairs Npm1/Npm2 (brpD)
and Npm3/Npm4 (brpI) were performed as described [7] to check
for proper integration of the cassette. Southern blot hybridizations
were used to confirm the mutant strains KG3-02 (brpD::aphA-3)
and KG3-17 (brpI::aphA-3).
Generation of in-frame brpA and brpJ deletion mutants
Deletions of brpA and brpJ were generated from the rugose strain
KG3(R) as follows. Using Pfu polymerase and PCR conditions as
described above, primers A and B amplified a 1-kb fragment at the
39 end of the target gene (AB), while primers C and D amplified a
1-kb fragment at the 59 end (CD). The resulting 1-kb AB & CD
fragments for a given gene were joined using splice overlap
extension with primers A and D as previously described [20] to
create a 2-kb deletion fragment. The fragment specific for brpA was
digested with EcoRI and BamHI and cloned into these sites on
pSP72, creating pVV27, while the brpJ-specific fragment was
digested with EcoRI and XbaI and cloned into these sites on pSP72
to create pVV42. The 840-bp nonpolar kanamycin cassette was
then cloned as a SmaI fragment in the correct orientation into the
SmaI site of each deletion clone to create pVV28 (brpA) and pVV44
(brpJ). Following sequencing as described earlier, the brpA deletion
construct containing the non-polar cassette was cloned as a 3-kb
EcoRI-HindIII fragment (made blunt ended with Klenow) into the
blunt-ended XbaI site of pGP704sacB28 to create pVV29, while
the same construct for brpJ was cloned as a 3-kb ClaI-XhoI
fragment (with ends filled) into the blunt-ended XbaI site of
pGP704sacB28 to create pVV46. Intergeneric matings, selection of
transconjugants and subsequent PCR analysis of potential mutants
were performed as described in the previous section, except that
primer pairs Del_wcrA_A/Del_wcrA_D (brpA) and Del_wcrJ_A/
Del_wcrJ_D (brpJ) were used for the latter step. Southern blot
hybridizations were used to confirm the mutant strains KG3-01
(DbrpA::aphA-3) and KG3-03 (DbrpJ::aphA-3).
Complementation of brp mutants
Complementation vectors pBBRBAD1 and pBBRBAD2 were
created by cloning the NcoI-SphI fragment of pBAD1/His
(Invitrogen), which contains the araC gene and arabinose-inducible
promoter PBAD, in either orientation into the broad-host-range
vector pBBR1MCS [21]. The brpA, brpD, brpI, brpJ, and brpIJK
genes were each amplified from YJ016 via PCR with primer pairs
wrcA-for/wcrA-Rev, Npm2/Npm13, Npm11/Npm12, wcrJ-For/
wcrJ-Rev, and wcrK-For/wcrIJK-Rev, respectively. Following
relevant restriction enzyme digestion, the amplified products were
cloned into the XhoI and HindIII, EcoRV and BamHI, XbaI and
PstI, SmaI and XbaI, and SmaI and XbaI sites of pBBRBAD1 or
pBBRBAD2 to create the respective plasmids pVV43 (brpA),
pVV41 (brpD), pVV40(brpI), pVV45(brpJ), and pVV53 (brpIJK).
Matings between the mutant strains and S17.1 harboring the
respective complementation plasmids were carried out as de-
scribed earlier, and transconjugants were selected with chloram-
phenicol. Complementation was typically assessed by adding 0.2%
arabinose to the growth media.
Microscopy
Whole colony images were taken using a Leica MZ7.5
stereomicroscope and a SPOT Insight camera (Diagnostic
Instruments, Inc.). Scanning electron microscopy (SEM) analysis
of colony surfaces was performed as previously described [7].
Analysis of the brp Locus of V. vulnificus
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Table 1. Strains used in this study.
Strain Genotype/Description Source or Reference
E. coli





S17.1 thi pro hsdR hdsM+ recA RP4-2-Tc::Mu-Km-Tn7 [37]
SY327lpir D(lac pro) argE(Am) rif malA recA56 lpir [38]
S17.1lpir thi pro hsdR hdsM+ recA RP4-2-Tc::Mu-Km-Tn7 lpir [37]
V. vulnificus
1003(O) formerly 1003; wound isolate from Louisiana, opaque [39]
BG(R) spontaneous rugose isolate of 1003(O) [6]
AZ(T) spontaneous translucent isolate of 1003(O) [32]
ABZ1(T) transposon mutant of 1003(O) (wcvA::mini-Tn10), TrS [32]
ABZ1(R) spontaneous rugose isolate of ABZ1(T) [6]
TDB3(T) transposon mutant of 1003(O) (brpI::mini-Tn10), TrS [13]
YJ016 clinical isolate from Taiwan, opaque [40]
KG3(R) spontaneous rugose isolate of YJ016 This study
KG4(T) spontaneous translucent isolate of YJ016 This study
KG3-17 non-polar brpI mutant of KG3(R), KmR This study
KG3-01 non-polar brpA mutant of KG3(R), KmR This study
KG3-02 non-polar brpD mutant of KG3(R), KmR This study
KG3-03 non-polar brpJ mutant of KG3(R), KmR This study
KG3-17C KG3-17 complemented with brpI gene on pVV40, KmR, ChlR This study
KG3-01C KG3-01, complemented with brpA gene on pVV43, KmR, ChlR This study
KG3-02C KG3-02, complemented with brpD gene on pVV41, KmR, ChlR This study
KG3-03C KG3-03, complemented with brpJ gene on pVV45, KmR, ChlR This study
TDB3(T)C1 TDB3(T), complemented with brpI gene on pVV40, KmR, ChlR This study
TDB3(T)C2 TDB3(T), complemented with brpIJK genes on pVV53, KmR, ChlR This study
YJ-10 non-polar brpJ mutant of YJ016, KmR This study
1001 blood isolate, opaque [39]
1004 stool isolate, opaque [39]
1005 blood isolate, opaque [39]
1007 blood isolate, opaque [39]
1009 blood isolate, opaque [39]
1014 blood isolate, opaque [39]
1456(O) unknown origin, opaque Lab collection
1456(T) spontaneous translucent variant of 1456(O) Lab collection
1657(O) unknown origin, opaque Lab collection
1657(T) spontaneous translucent variant of 1657(O) Lab collection
95-10-15 unknown origin, opaque Lab collection
96-7-155 eel isolate, opaque Lab collection
ATCC27562 clinical isolate, opaque [41]
C7184 clinical isolate, opaque [42]
CMCP6 clinical isolate, opaque [43]
CP-Clam-2 oyster isolate, opaque Lab collection
CP-Mussel-10 oyster isolate, opaque Lab collection
CP-Sed-5 sediment isolate, opaque [8]
F8Oyster11(O) oyster isolate, opaque Lab collection
F8Oyster11(T) spontaneous translucent variant of F8Oyster11(O) Lab collection
MLT124 oyster isolate, opaque [8]
MLT136(O) formerly MLT136; oyster isolate, opaque [8]
MLT136(T) spontaneous translucent isolate of MLT136(O) Lab collection
Analysis of the brp Locus of V. vulnificus
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Table 1. Cont.
Strain Genotype/Description Source or Reference
MLT141 oyster isolate, opaque Lab collection
MLT198 sediment isolate, translucent Lab collection
132a1 environmental isolate, opaque M.E. Janes
132z2 environmental isolate, opaque M.E. Janes
212b6 environmental isolate, opaque M.E. Janes
212f12 environmental isolate, opaque M.E. Janes
212s7 environmental isolate, opaque M.E. Janes
342e9 environmental isolate, opaque M.E. Janes
342s6 environmental isolate, opaque M.E. Janes
NOLA18 environmental isolate, New Orleans, LA, opaque Lab collection
212f18 environmental isolate, opaque M.E. Janes
doi:10.1371/journal.pone.0100890.t001
Table 2. Plasmids used in this study.
Plasmid Description Reference/source
Vectors
pSP72 cloning vector, ApR Promega
pGP704sacB28 suicide vector, ApR [19]
pBBR1MCS broad host range cloning vector, ChlR [21]
pACW29 contains the 840bp nonpolar KmR cassette inserted in wzaVv, Km
R [11]
pKan2 contains the 840bp nonpolar KmR cassette of pACW29 cloned into pSP72, KmR This study
pBAD/His A expression vector containing the araC gene and PBAD promoter, Ap
R Invitrogen
pBBRBAD1 PBAD promoter and araC gene cloned into pBBR1MCS, Chl
R This study
pBBRBAD2 PBAD promoter and araC gene in the opposite orientation of pBBRBAD1, Chl
R This study
Non-polar mutagenesis clones
pVV4 brpI fragment cloned into pSP72, ApR This study
pVV8 nonpolar KmR cassette inserted in the brpI fragment of pVV4, ApR, KmR This study
pVV18 brpI-KmR cassette fusion from pVV8 cloned into pGP704sacB28, ApR, KmR This study
pVV1 brpD fragment cloned into pSP72, ApR This study
pVV2 nonpolar KmR cassette inserted in the brpD fragment of pVV1, ApR, KmR This study
pVV21 brpD-KmR cassette fusion from pVV2 cloned into pGP704sacB28, ApR, KmR This study
pVV27 brpA deletion (DbrpA) fragment cloned into pSP72, ApR This study
pVV28 nonpolar KmR cassette inserted in the DbrpA fragment of pVV27, ApR, KmR This study
pVV29 DbrpA-KmR cassette fusion from pVV28 cloned into pGP704sacB28, ApR, KmR This study
pVV42 brpJ deletion (DbrpJ) fragment cloned into pSP72, ApR This study
pVV44 nonpolar KmR cassette inserted in the DbrpJ fragment of pVV42, ApR, KmR This study
pVV46 DbrpJ-KmR cassette fusion from pVV44 cloned into pGP704sacB28, ApR, KmR This study
Complementation/overexpression clones
pVV40 brpI gene cloned into pBBRBAD2, ChlR This study
pVV41 brpD gene cloned into pBBRBAD2, ChlR This study
pVV43 brpA gene cloned into pBBRBAD1, ChlR This study
pVV45 brpJ gene cloned into pBBRBAD2, ChlR This study
pVV53 brpIJK genes cloned into pBBRBAD2, ChlR This study
ApR, ampicillin resistant; KmR, kanamycin resistant, ChlR, chloramphenicol resistant.
doi:10.1371/journal.pone.0100890.t002
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EPS isolation and visualization
EPS was isolated as previously described [22] with modifica-
tions. Two related protocols were performed with similar results.
In the first protocol, a single colony was used to inoculate an entire
plate of HI (with necessary antibiotics), which was incubated at
room temperature (RT) for 2 days (2 plates were used for strain
KG3-03 due to its relatively slow growth). Each lawn was collected
by scraping with a glass pipette in the presence of PBS, and the
resulting suspension was stirred briskly for 1-2 h at RT and then
vigorously vortexed for 30 sec. Cells were harvested by centrifu-
gation at 8,000 rpm for 1 h at 4uC, and a 5-ml aliquot of the
supernatant was treated with 50 mg/ml RNase A (Qiagen) and
50 mg/ml DNase (Promega) in the presence of 10 mM MgCl2 at
37uC for 8 h, followed by treatment with 200 mg/ml protease
(Sigma) at 37uC for 17.5 h. The supernatant was then extracted
twice with an equal volume of phenol:chloroform (50:50), and EPS
was precipitated by the addition of 2 volumes of 100% ethanol.
EPS was pelleted in a microfuge at 10,000 rpm for 30 min at 4uC,
and the pellet was washed with 70% ethanol, dried and finally
resuspended in 100 ml dH2O. An equal volume of each sample
was then analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) (100 V, 2–3 h) using 4% stacking/10% resolving gels.
Finished gels were stained with Stains-All as previously described
[23]. In the second protocol, a single colony was used to inoculate
plates as before, except that 3 plates were used per strain.
Following incubation, the lawns for a given strain were collected
by scraping, the resulting suspension was vortexed vigorously for
1 min, and a 20-ml aliquot was used to create serial dilutions,
which were plated on HI (with necessary antibiotics) to calculate
CFU/ml of the cell suspension. The suspension was then shaken at
30uC for 90 min, and the vortexing and shaking was repeated a
second time. Cells were harvested by centrifugation at 5,000 rpm
























1Restriction enzyme sites are underlined. Homologous sequence used in SOE is
italicized. SmaI sites are in bold.
2From Grau, et al. 2008 [7].
doi:10.1371/journal.pone.0100890.t003
Table 4. Primers used for brp distribution analysis.
Primer Sequence (59R39) Description
RUG131 CGAGAGAGATGAGAGCAATG Used to demonstrate brpA-brpB linkage
RUG161 TTCCTCTCGCAATACGCCAC Used to demonstrate brpA-brpB linkage
RUG151 CAAGAGCATACGACCTGGAC Used to demonstrate brpB-brpC linkage
RUG181 TGGCGAGGATGACTTATCAA Used to demonstrate brpB-brpC linkage
RUG191 ACGCAGACCTCCACTAGAGA Used to demonstrate brpD-brpF linkage
RUG341 GAAGGTGCAGGAAGAGTTGA Used to demonstrate brpD-brpF linkage
CAP251 GTAGAGTGGCAGATCGTACA Used to demonstrate brpH-brpI linkage
CAP281 TGTCACGCAACTGCTGTTCT Used to demonstrate brpH-brpI linkage
CAP271 TACCAATCTAACGCCGGCAA Used to demonstrate brpI-brpJ linkage (also used with CAP28 to generate brpI
probe)
RUG451 AATCCAATGAGCAGCGAAGTCC Used to demonstrate brpI-brpJ linkage
RUG43 AGCCAGAAGATAGCCTGTC Used to demonstrate brpJ-brpK linkage
RUG461 AGCGATACGCCATGTTACTCC Used to demonstrate brpJ-brpK linkage
RUG331 GAAGGTGCAGGAAGAGTTGA Used to generate brpF probe (with RUG34)
RUG44 GGAGTCGAGCTCTTCATTCC Used to generate brpK probe (with RUG43)
RUG17 CGGAACTTATTAATCGAGAC Used with RUG18 to generate brpC probe
wza-For2 GGTGCTCTACGCGTTAAAACG Used to amplify wzb gene
wzc-Rev2 GAGTTATCAACGGAAGATCGG Used to amplify wzb gene
1From Grau, et al. 2008 [7].
2From Garrison-Schilling, et al. 2011 [8].
doi:10.1371/journal.pone.0100890.t004
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for 15 min at 25uC, and the supernatant was re-centrifuged using
the same parameters. The resulting supernatant was treated with
RNaseA, DNase and protease, extracted twice with phenol:chloro-
form (50:50) and polysaccharide was precipitated with 100%
ethanol, all as in the first protocol. SDS-PAGE and staining were
performed also as before, except that sample volumes were
adjusted for differences in CFU/ml of the original cell suspensions.
Pellicle and biofilm assays
Pellicle formation was observed after ON growth at 30uC in
3 ml HI (with necessary antibiotics and/or arabinose) with shaking
at 200 rpm. Pellicle thickness was scored qualitatively as — (no
pellicle), + (thin pellicle), ++ (pellicle), or +++ (thick pellicle). Three
pellicles for each strain were scored. Biofilm assays were conducted
as previously described [8], except static cultures were incubated
for 18 h. At least two independent assays with six replicates of each
strain were completed.
Motility assays
Motility assays were conducted as previously described [6]. At
least two independent assays with four replicates of each strain
were completed.
Statistical Analysis
All data were analyzed using a non-paired Student’s t-test.
Results
Phenotypic characterization of individual brp mutants
Given the possibility of co-transcription of the brp gene cluster
(Figure 1A), a mutagenesis approach involving insertion of a non-
polar kanamycin resistance cassette [18] was used in a rugose
background to assess the contribution of select brp genes to
rugosity, biofilm formation, exopolysaccharide production and
motility. As shown previously, the presence of conserved domains
revealed putative function for some of the brp genes while, for
others, no conserved domains were apparent [7]; here, we chose to
mutate four genes for which putative functions had been identified
(Figure 1A). For the first two mutants, the kanamycin-resistant
cassette was inserted between encoded functional domains of the
brpD and brpI genes. Though, as detailed below, this approach
yielded clear mutant phenotypes consistent with previous plasmid
insertions into the locus [12], we were concerned that continued
use of such a strategy would leave open the possibility of creating a
truncated product which retained activity; thus, for the brpA and
brpJ mutants, a different approach was employed which resulted in
nearly the entire gene being replaced by the cassette (Figure 1A).
The brpA [KG3-01], brpD [KG3-02], and brpI [KG3-17]
mutants lost the dry, wrinkled colony morphology of the
KG3(R) parent, but appeared opaque, indicating they retained
the ability to make CPS (Figure 1B–C). Meanwhile, the brpJ
mutant (KG3-03) also lost its wrinkled look, though it remained
dry in appearance with faint striations that became more
pronounced upon extended incubation; thus, it possessed an
intermediate phenotype which did not match any of the typical
opaque, translucent or rugose colony types (Figure 1B–C). KG3-
03 also grew detectably slower (by ,50%) relative to the parent
and other mutants (data not shown). It is unknown to what extent,
if any, this defect contributed to the unique colonial phenotype of
this mutant. Each mutant was then complemented using a cloned
arabinose-inducible promoter construct which could induce
expression of a wild type copy of each gene. The rugose colony
phenotype was restored for each complemented mutant, although
the degree of rugosity was clearly greater for KG3-02 containing
the brpD complementation vector pVV41 (Figure 1B).
The complementation shown in Figure 1B was performed on
plates containing 0.2% arabinose. When the concentration of
arabinose was titrated (i.e., 0.02% and 0.002%), the strongest
complementation was still always seen for KG3-02 (pVV41) (data
not shown). Despite this effect, when pVV41 was introduced into
strain KG3(R), rugosity of the parental strain did not appear to be
increased relative to KG3(R) itself or KG3(R) containing the brpI
complementation vector pVV40 (data not shown).
The opaque phenotype of the brpI mutant KG3-17 was
consistent with a previous plasmid insertion into that gene [12]
but not with the translucent phenotype of mutant TDB3(T) [13].
This mutant was derived from an opaque strain and contains a
mini-Tn10 insertion in the brpI gene. Upon further analysis of
TDB3(T), we found here that it could not be complemented back
to opacity with either the brpI gene alone (plasmid pVV40), or with
brpI and the downstream brpJ and brpK genes (plasmid pVV53) all
together (data not shown). Thus, it was unlikely that brp gene
disruption was the cause of the translucent phenotype of TDB3(T).
To further explore the genetic basis of this mutant, PCR was used
to assess its wzb gene. It has been shown that deletions in the wzabc
region of the group I CPS operon can cause an irreversible switch
from the opaque to the translucent phenotype [10]. The wzb gene
was still present with no mutations (data not shown), suggesting the
translucent phenotype of TDB3(T) is the result of a separate
genetic or epigenetic change somewhere in the genome.
Since rugose isolates form robust biofilms [6], we expected that
the brp mutants isolated here would produce less biofilm. Biofilm
formation was assessed both qualitatively (pellicle formation) and
quantitatively (biofilm assays). All four brp mutants lost the ability
to form a pellicle, and pellicle formation was partially or fully
restored upon complementation (Figure 2A). In quantitative
biofilm assays, all four mutants formed significantly less biofilm
than their rugose parent KG3(R) (max p,0.001), and biofilm
formation was again partially or fully restored upon complemen-
tation (Figure 2B).
We hypothesized that the intermediate phenotype of the brpJ
mutant KG3-03 may be associated with a partial reduction, rather
than complete loss, of brp-encoded EPS on the cell surface.
Consistent with this view, a non-polar brpJ mutant of the opaque
strain YJ016 (YJ-10) remained opaque (Figure 1D), indicating that
deletion of brpJ per se does not appear to affect CPS production.
To assess relative EPS production of KG3-03 directly, we
compared the amount of EPS isolated from rugose strain
KG3(R) and its four brp mutant derivatives. The data in Figure 3
show that much less EPS was recovered from KG3-03 cells than
KG3(R), but reproducibly more than the other brp mutants, which
did not yield detectable amounts of EPS in this analysis.
To obtain further evidence consistent with EPS production by
KG3-03, colonies of this strain, as well as several others, were
subjected to SEM analysis. Previous SEM studies indicated that
opaque and translucent variants of V. vulnificus have smooth colony
surfaces with flat architecture, while EPS-producing rugose
variants have wrinkled surfaces and dramatic three-dimensional
architectures consisting of pillars and channels [7]. Here, we found
that while the smooth flat colony surfaces of the brpI mutant KG3-
17 (Figure 4, panel D) appeared indistinguishable from those of
KG4(T) and YJ016 (panels B and C, respectively), the surface of
KG3-03 colonies showed evidence of striations even at relatively
low magnification (panel E); upon higher magnification, the
striated areas corresponded to partial three-dimensional structur-
ing, which is consistent with production of EPS (panel F). While
the EPS isolation results and SEM data support the notion that the
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brpJ gene product was not absolutely required for brp-encoded EPS
production to occur in strain KG3-03, it was nevertheless found to
be necessary for production of a pellicle and robust biofilm
formation under the conditions tested (Figure 2A–B).
As rugose isolates of V. vulnificus are less motile than their
opaque or translucent counterparts [6], we measured the motility
of each brp mutant described here and found that their motilities
remained at low levels similar to the rugose parental strain
(Figure 5A–B). The motility of KG3-03 was significantly less than
KG3(R) (and the other mutants), but we attribute this to its slower
growth rate (data not shown). The observation that KG3 mutants
retained the reduced motility of KG3(R) suggests that elimination
or reduction of EPS production does not appear to affect (i.e.,
increase) motility in this species.
Evidence of the brp locus being widespread among
strains of V. vulnificus
Since the brp locus is required for rugosity and efficient biofilm
formation, it may provide a survival advantage in the environ-
ment, and, as such, it would be predicted to be well-conserved
among strains of this species. This possibility was tested by
screening for the presence of the brp cluster in a number of clinical
and environmental strains. Linkage PCR was used as previously
described [7] to determine that 41 of the 42 V. vulnificus strains in
our collection contained the brp locus (Table 5). The lone
exception was the environmental isolate MLT198, which was
locked in the translucent phase based on switching assay results
(data not shown). To further characterize the brp genes in the 41
brp+ strains, Southern blot hybridization was performed, and it
showed that 20 of the strains were of a single 10.5 kb PstI
Figure 1. Phenotypes of individual brp gene mutants. A. Diagram of mutant construction for 4 brp genes. Open rectangles indicate the non-
polar KanR cassette, while the filled rectangle indicates the mini-Tn10 insertion in strain TDB3(T) (41). Shading of arrows for the brp cluster indicates
putative function encoded: black, flippase involved in EPS transport (for brpJ) or EPS export-related protein (for brpC); light grey, tyrosine autokinase
involved in EPS biosynthesis; dark grey, glycosyltransferase involved in EPS biosynthesis; white, unknown function. B. Colony morphology of opaque,
rugose, and translucent control variants, the 4 brp mutant strains derived from strain KG3(R), and the complemented mutants. Strains were streaked
for isolation on HI agar (containing kanamycin, chloramphenicol and arabinose, as appropriate) and incubated at 30uC ON. C. Streak plate of opaque,
rugose, and translucent control variants and the 4 brp mutant strains. Strains were inoculated into HI broth (with kanamycin, where appropriate),
shaken ON at 30uC, streaked onto HI (with no antibiotics), and incubated ON at 30uC. D. Colony morphology of the YJ016-derived brpJ mutant YJ-10.
The strain was streaked for isolation on HI agar containing kanamycin and incubated at 30uC ON.
doi:10.1371/journal.pone.0100890.g001
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restriction fragment length polymorphism (RFLP) profile while 6
others were of a single 2.7-kb PstI profile (Table 5). The exact
profile of the other 15 could not be determined from the available
data. All representatives of each RFLP profile group tested showed
the ability to switch to the rugose colony type and produce pellicles
in culture (data not shown).
Discussion
Here we assessed individual genes within the brp cluster for their
contribution to rugose colony morphology, biofilm formation, EPS
production, and motility. The apparent lack of brp-encoded EPS
production for the brpA, brpD, and brpI mutants suggests these
genes designate required functions. Consistent with this interpre-
tation, the brpA and brpI genes are predicted to encode
glycosyltransferases, which are enzymes that catalyze the sequen-
tial transfer of specific individual sugars to an undecaprenyl
phosphate carrier lipid during the early steps of polysaccharide
synthesis [24]. The brpD gene product also appears to be involved
in polysaccharide biosynthesis and may play a role in EPS
production similar to Wzc, a tyrosine autokinase which is required
for assembly of high-molecular-weight CPS and EPS polymers on
the bacterial cell surface [7,24]. The finding here that brpD is
required for EPS production is consistent with the results for
capsule but not KLPS synthesis in E. coli K30 wzc mutants [24].
On the other hand, the brpJ gene appears to be involved in
polysaccharide transport as its product has homology to Wzx
flippases [7], which are transmembrane proteins that have been
proposed to translocate undecaprenyl-phosphate-linked sugar
precursors across the cytoplasmic membrane during synthesis of
various polysaccharides including certain forms of CPS, EPS and
O-antigens of LPS [24,25]. The reduction, but not elimination, of
EPS production in the KG3(R)-derived brpJ mutant is reminiscent
Figure 2. Biofilm formation by individual brp gene mutants. Biofilm formation was assessed qualitatively and quantitatively for opaque,
rugose, and translucent control variants, the 4 brp mutant strains, and the complemented mutants. A. Following ON growth with shaking, 3 cultures
per strain were assessed for pellicle formation and a representative is pictured. Pellicle thickness was scored qualitatively as — (no pellicle), + (thin
pellicle), ++ (pellicle), or +++ (thick pellicle). B. Biofilm assays were performed on at least 6 independent culture replicates of each statically grown
strain and OD570 values, which correspond to the amount of crystal violet staining of biofilm material, were averaged. Averages 6 standard
deviations (SD) are pictured here. Asterisk denotes p,0.001 versus KG3(R).
doi:10.1371/journal.pone.0100890.g002
Figure 3. Evidence of EPS production for brpJ mutant strain
KG3-03. An EPS extraction procedure (see Materials and Methods for
details) was performed on KG3(R) and the 4 brp mutant strains, and the
results were analyzed by SDS-PAGE using 4% stacking/10% resolving
gels and subsequent staining with Stains-All.
doi:10.1371/journal.pone.0100890.g003
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of the results seen previously for knockout of the wzxE flippase
gene, which is involved in synthesis of phosphoglyceride-linked
and cyclic forms of enterobacterial common antigen in E. coli [26],
and the production of EPS here suggests a couple of possible
explanations. As complementation among Wzx proteins has been
demonstrated [27], albeit often at much reduced efficiency [28], it
is possible that loss of brpJ function can be partially compensated
for (either naturally or via suppressor mutation) by a separate Wzx
protein encoded by V. vulnificus. In this case, a potential candidate
may be the wzx gene found in the Group I CPS operon [7].
Alternatively, it is known that transport of polysaccharides across
the inner membrane of Gram-negatives actually involves two
different pathways: one requiring Wzx, which may use an antiport
mechanism to flip substrates [29], and the other requiring an ABC
transporter [24,30]. Such movement of individual polysaccharides
has long been considered to occur exclusively by one or the other
of these pathways; however, using an artificially constructed
genetic system, there is now evidence that translocation of at least
some lipid-linked oligosaccharides across the inner membrane can
be accomplished using either Wzx or ABC transporter function
Figure 4. Evidence of three-dimensional structuring of KG3-03 colonies. Whole colonies taken from HI agar plates were vapor fixed with
osmium tetroxide and viewed by SEM as described previously [7]. Panels: (A), KG3(R); (B) YJ016; (C), KG4(T); (D) KG3-17; (E, F) KG3-03. All scale bars
equal 100 mm. Images in panels E and F are taken from the same colony. All images presented are representative of many images taken for several
colonies of each strain. To achieve uniformity, brightness was increased somewhat for images in panels A, B, D and F, while it was decreased for the
image in panel C. Contrast was not adjusted for any of the images.
doi:10.1371/journal.pone.0100890.g004
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[31]. Therefore another possibility is that an undetermined ABC
transporter may also be capable of translocating brp-encoded EPS
polymers across the inner membrane in V. vulnificus.
Based on the results of the EPS isolation for mutants KG3-01,
KG3-02 and KG3-17 (Figure 3), we found no evidence of rbd-
encoded EPS production under the experimental conditions used
here. Our results were not surprising given the previous data
showing that the rbd locus is poorly transcribed under standard lab
conditions and is under the control of a two-component sensor
kinase/response regulator whose environmental induction signal(s)
remains unknown [16]. In any event, the finding that rbd
polysaccharide does not contribute to rugosity [16] supports the
conclusion that the EPS found here on the surface of the brpJ
mutant KG3-03 is brp-encoded.
We also found no evidence that CPS expression is controlled by
the brp locus, which is in agreement with the previous results of
Guo and Rowe-Magnus [12]. Additionally, our results point to
another potential mechanism for the creation of phase-locked
translucent variants. The transposon mutant TDB3(T), which is
derived from the clinical isolate 1003(O), could not be comple-
mented with the brpIJK genes and its wzb gene remained intact,
indicating its translucent phenotype is due to an uncharacterized
genetic or epigenetic change. Previous transposon mutagenesis of
1003(O) revealed additional genes that appear to be involved in
CPS production in that strain [13,32]. A mutation in any of these
Figure 5. Motilities of individual brp mutants are similar to the
KG3(R) parent. Motility of opaque, rugose, and translucent control
variants, 4 brp mutant strains, and the complemented strains on
motility agar plates was observed (A) and quantified (B) for at least 10
replicates of each strain. Averages 6 SD are pictured here. Asterisk
denotes p,0.002 versus KG3(R).
doi:10.1371/journal.pone.0100890.g005
Table 5. Distribution of the brp cluster among V. vulnificus
strains.





















CP Clam 2 + 10.5
CP Mussel 10 + –
CP Sed 5 + 10.5
F8 Oyster 11(O) + 10.5
F8 Oyster 11(T) + 10.5
KG3(R) + 10.5
KG4(T) + 10.5
MLT 124 + 10.5
MLT 136(O) + 10.5
MLT 136(T) + 10.5
MLT 141 + 10.5











1+ or – indicates the presence or absence, respectively, of all genes in the brp
cluster.
2Indicates the size of the band hybridized to a radiolabeled probe specific for
brpC or brpI. A – indicates that either no bands were present or that band size
could not be determined.
doi:10.1371/journal.pone.0100890.t005
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genes or in an additional unidentified gene that affects CPS
expression could explain the translucent phenotype of TDB3(T).
Biofilm development occurs in an ordered series of events which
begins with initial attachment of planktonic cells to a surface,
colonization of that surface, and then development of a three-
dimensional architecture [33]. Biofilm formation provides a
distinct survival advantage for microbes, because it not only
allows them to bind to surfaces that may provide nutrients, but
also makes them more resistant to environmental stresses [34,35].
Consistent with such an advantage we found the brp locus to be
highly prevalent among V. vulnificus strains tested. Further
elucidation of the loci that play roles in EPS production in V.
vulnificus will continue to provide important insights regarding the
genetic and physiological bases for biofilm formation by this
marine inhabitant and occasional human pathogen.
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